ROLFE PANCREATIC CANCER FOUNDATION

Dr. Mark Talamonti | 2025 Rolfe Resilience Award
Visionary, Champion, Mentor

Dr. Mark Talamonti is a Professor of Surgery at the University of Chicago Pritzker School of Medicine and currently serves as the Chairman of the Department of Surgery at Endeavor Health. His clinical expertise focuses on gastrointestinal surgical oncology with specific interests in pancreatic cancer. Dr. Talamonti is a dedicated advocate for research, education, and exploring robotic and other cutting-edge surgical advancements that offer hope to pancreatic cancer patients. The Rolfe Resilience Award recognizes individuals, like Dr. Talamonti, who have chosen to use their platform and skills to make a difference by becoming leaders, activists, and changemakers in the pancreatic cancer field.

Harriet’s Helping Hands, In Honor of Harriet Wulfstat |
2025 Rolfe Philanthropy Award
Humanitarian, Changemaker, Advocate

Rolfe Foundation’s patient and family support program, Harriet’s Helping Hands, was created in memory of and to honor Harriet Wulfstat, a committed and innovative former Board Member. The program is generously funded by the Gerald O Mann Foundation of which her family are the trustees. As a cancer patient herself who suffered with, not one, but two separate pancreatic cancer diagnoses more than 10 years apart, Harriet experienced first hand the need for a support program. Her legacy lives on in every connection made, every hand held, ensuring no one fights this disease alone. Harriet brought joy, kindness, and passion to everything she did and was deeply devoted to her family, friends, and community. The Philanthropy Award recognizes individuals who have played an important role in our mission. This compassionate program has helped thousands of families receive guidance and resources to navigate and fight this terrible disease.

Tempus | Ezra Cohen, Chief Medical Officer of Oncology, Accepting on Behalf of Tempus | 2025 Rolfe Resilience Award
Innovator, Futurist, Builder

Tempus is at the forefront of transforming cancer care through its groundbreaking use of artificial intelligence and multimodal data. As the recipient of the 2025 Rolfe Resilience Award, Tempus is recognized for its unwavering commitment to helping people live longer, healthier lives. Tempus directly aligns with the mission of Rolfe Foundation.